Technical aspects of nuchal translucency measurement

Seminars in Perinatology

Volumn 29, Issue 6, 2005, Pages 376-379

  Abuhamad, Alfred ^a,b  

^a EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^b NONE   (United States)

Author keywords

Down syndrome; NT; Nuchal translucency; Technical aspects

Indexed keywords

AMNION; CHROMOSOME ABERRATION; CONGENITAL DISORDER; DOWN SYNDROME; FIRST TRIMESTER PREGNANCY; HUMAN; NUCHAL TRANSLUCENCY MEASUREMENT; PRIORITY JOURNAL; REVIEW; ULTRASOUND;

ABNORMALITIES; CHROMOSOME ABERRATIONS; CREDENTIALING; DOWN SYNDROME; FEMALE; HUMANS; NUCHAL TRANSLUCENCY MEASUREMENT; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY TRIMESTER, SECOND;

EID: 33644913401     PISSN: 01460005     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.semperi.2005.12.004     Document Type: Review

References (4)

1. R.L. Snijders, P. Noble, N. Sebire UK multicenter project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation Lancet 352 1998 343 346
2. R. Wapner, E. Thom, J.L. Simpson First trimester screening for trisomies 21 and 18 N Engl J Med 349 2003 1405 1413
3. F.D. Malone, J.A. Canick, R.H. Ball First-trimester or second trimester screening, or both for Down's syndrome N Engl J Med 353 2005 2001 2011
4. J.E. Haddow, G.E. Palomaki, G.J. Knight Screening of maternal serum for fetal Down's syndrome in the first trimester N Engl J Med 338 1998 955 961